Funding Announcements

"We are delighted in raising investment from Jenson Funding Partners and continuing our incredible journey with their support. AscensionQ was created to tackle the everyday challenges researchers face through automation in one platform, connecting people and not just processes. It has been fantastic working with the research community to create ‘a first of its kind’ research clinic operating system. From well-established research institutions through to newer organisations, the AQ platform has shown to increase clinical trial capacity for hospitals, improve patient recruitment and retention and support the business opportunity that research presents for NHS trusts. Our ‘buy-once, use many’ philosophy has enabled our customers to do more with less. 2022 was great validation of our system and for 2023 we are excited to push on and help the thousands of research clinics in the UK and beyond."

"Existing data suggests that current approaches fall short at accurately detecting and localizing the deadliest cancers that desperately need to benefit from a blood test. At OXcan, we are using state-of-art and unbiased high-throughput proteomics approaches to examine hundreds and thousands of proteins in blood samples from largest studies of their kind for the first time. Combined with proprietary and tailored machine learning approaches, the results are products that fully integrate with existing care pathways and can detect and localize the deadliest cancers with unprecedented sensitivity and specificity."

"Hearing loss usually advances slowly and unnoticeably and has severe consequences if left unmanaged. Our mission is to make reliable hearing testing accessible outside of specialist clinics to drive the early diagnosis of hearing loss and to ensure positive patient outcomes."

"We are proud to be partnering with Stratasys, and have always believed in their technology and, more importantly, their vision for 3D printing in healthcare,"